Antibody drug conjugates: hitting the mark in pancreatic cancer?

Pancreatic cancer is one of the most common causes of cancer-related death, and the 5-year survival rate has only improved marginally over the last decade. Late detection of the disease means that in most case...

Source: Journal of Experimental and Clinical Cancer Research - October 25, 2023 Category: Cancer & Oncology Authors: Nicole L. Wittwer, Michael P. Brown, Vasilios Liapis and Alexander H. Staudacher Tags: Review Source Type: research